Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin

Ying Cao,1,* Yibei Dai,1,* Lingyu Zhang,1 Danhua Wang,1 Wen Hu,2 Qiao Yu,3 Xuchu Wang,1 Pan Yu,1 Weiwei Liu,1 Ying Ping,1 Tao Sun,1 Yiwen Sang,1 Zhenping Liu,4 Yan Chen,3 Zhihua Tao1 1Department of Laboratory Medicine, Zhejiang University School of Medicine Second Affiliated Hospital...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cao Y, Dai Y, Zhang L, Wang D, Hu W, Yu Q, Wang X, Yu P, Liu W, Ping Y, Sun T, Sang Y, Liu Z, Chen Y, Tao Z
Format: article
Langue:EN
Publié: Dove Medical Press 2021
Sujets:
inflammatory bowel disease
fecal biomarkers
oncostatin m
calprotectin
diagnosis
activity
infliximab response
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Accès en ligne:https://doaj.org/article/66e06f62a534404c901716fefdb9cf78
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/66e06f62a534404c901716fefdb9cf78

Documents similaires